Radiotherapy With Double Checkpoint Blockade of Locally Advanced HNSCC

Condition:   Locally Advanced Head and Neck Squamous Cell Carcinoma
Intervention:   Combination Product: Durvalumab + Tremelimumab + RT
Sponsor:   University of Erlangen-Nürnberg Medical School
Not yet recruiting

http://ift.tt/2nLSH1D